MODERNA INC (0QF.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:0QF - US60770K1079 - Common Stock
30.04 EUR
-0.28 (-0.91%)
We assign a fundamental rating of 3 out of 10 to 0QF. 0QF was compared to 83 industry peers in the Biotechnology industry. 0QF scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 0QF is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year 0QF has reported negative net income.
0QF had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 0QF reported negative net income in multiple years.
In multiple years 0QF reported negative operating cash flow during the last 5 years.
1.2 Ratios
0QF has a Return On Assets of -25.68%. This is comparable to the rest of the industry: 0QF outperforms 51.81% of its industry peers.
The Return On Equity of 0QF (-33.40%) is better than 63.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.68% | ||
| ROE | -33.4% | ||
| ROIC | N/A |
ROA(3y)-6.14%
ROA(5y)4.17%
ROE(3y)-7.66%
ROE(5y)6.83%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 63.49%, 0QF is in line with its industry, outperforming 57.83% of the companies in the same industry.
0QF's Gross Margin has declined in the last couple of years.
0QF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.49% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
0QF does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 0QF has more shares outstanding
Compared to 5 years ago, 0QF has more shares outstanding
0QF has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.71 indicates that 0QF is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.71, 0QF is doing good in the industry, outperforming 75.90% of the companies in the same industry.
0QF has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
0QF has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. 0QF outperforms 87.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.71 |
ROIC/WACCN/A
WACC8.73%
2.3 Liquidity
0QF has a Current Ratio of 3.93. This indicates that 0QF is financially healthy and has no problem in meeting its short term obligations.
0QF's Current ratio of 3.93 is fine compared to the rest of the industry. 0QF outperforms 74.70% of its industry peers.
0QF has a Quick Ratio of 3.73. This indicates that 0QF is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of 0QF (3.73) is better than 78.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.93 | ||
| Quick Ratio | 3.73 |
3. Growth
3.1 Past
The earnings per share for 0QF have decreased strongly by -38.66% in the last year.
0QF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -56.07%.
Measured over the past years, 0QF shows a very strong growth in Revenue. The Revenue has been growing by 122.01% on average per year.
EPS 1Y (TTM)-38.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1800%
Revenue 1Y (TTM)-56.07%
Revenue growth 3Y-44.04%
Revenue growth 5Y122.01%
Sales Q2Q%-45.44%
3.2 Future
Based on estimates for the next years, 0QF will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.53% on average per year.
0QF is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.90% yearly.
EPS Next Y11.47%
EPS Next 2Y11.1%
EPS Next 3Y13.46%
EPS Next 5Y16.53%
Revenue Next Year-40.97%
Revenue Next 2Y-22.34%
Revenue Next 3Y-11.19%
Revenue Next 5Y11.9%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
0QF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year 0QF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
0QF's earnings are expected to grow with 13.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.1%
EPS Next 3Y13.46%
5. Dividend
5.1 Amount
0QF does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:0QF (1/9/2026, 7:00:00 PM)
30.04
-0.28 (-0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners71.72%
Inst Owner ChangeN/A
Ins Owners2.73%
Ins Owner ChangeN/A
Market Cap11.74B
Revenue(TTM)2.23B
Net Income(TTM)-3.12B
Analysts55.86
Price Target31.94 (6.32%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)52.94%
Min EPS beat(2)29.6%
Max EPS beat(2)76.27%
EPS beat(4)3
Avg EPS beat(4)30.21%
Min EPS beat(4)-6.26%
Max EPS beat(4)76.27%
EPS beat(8)7
Avg EPS beat(8)49.68%
EPS beat(12)9
Avg EPS beat(12)9.25%
EPS beat(16)12
Avg EPS beat(16)10.78%
Revenue beat(2)2
Avg Revenue beat(2)17.81%
Min Revenue beat(2)12.36%
Max Revenue beat(2)23.26%
Revenue beat(4)3
Avg Revenue beat(4)8.94%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)23.26%
Revenue beat(8)7
Avg Revenue beat(8)29.87%
Revenue beat(12)10
Avg Revenue beat(12)27.21%
Revenue beat(16)13
Avg Revenue beat(16)22.97%
PT rev (1m)-10.15%
PT rev (3m)-20.23%
EPS NQ rev (1m)0.31%
EPS NQ rev (3m)6.6%
EPS NY rev (1m)1.09%
EPS NY rev (3m)17.66%
Revenue NQ rev (1m)0.88%
Revenue NQ rev (3m)-12.85%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)-1.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 6.14 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.47 | ||
| P/tB | 1.48 | ||
| EV/EBITDA | N/A |
EPS(TTM)-6.91
EYN/A
EPS(NY)-6.09
Fwd EYN/A
FCF(TTM)-5.84
FCFYN/A
OCF(TTM)-4.34
OCFYN/A
SpS4.89
BVpS20.46
TBVpS20.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.68% | ||
| ROE | -33.4% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.49% | ||
| FCFM | N/A |
ROA(3y)-6.14%
ROA(5y)4.17%
ROE(3y)-7.66%
ROE(5y)6.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.55%
GM growth 5YN/A
F-Score2
Asset Turnover0.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 329.33% | ||
| Cap/Sales | 30.69% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.93 | ||
| Quick Ratio | 3.73 | ||
| Altman-Z | 3.71 |
F-Score2
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)261.63%
Cap/Depr(5y)224.68%
Cap/Sales(3y)14.96%
Cap/Sales(5y)10.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1800%
EPS Next Y11.47%
EPS Next 2Y11.1%
EPS Next 3Y13.46%
EPS Next 5Y16.53%
Revenue 1Y (TTM)-56.07%
Revenue growth 3Y-44.04%
Revenue growth 5Y122.01%
Sales Q2Q%-45.44%
Revenue Next Year-40.97%
Revenue Next 2Y-22.34%
Revenue Next 3Y-11.19%
Revenue Next 5Y11.9%
EBIT growth 1Y-46.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.1%
EBIT Next 3Y15.77%
EBIT Next 5Y17.94%
FCF growth 1Y-0.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.81%
OCF growth 3YN/A
OCF growth 5YN/A
MODERNA INC / 0QF.DE FAQ
Can you provide the ChartMill fundamental rating for MODERNA INC?
ChartMill assigns a fundamental rating of 3 / 10 to 0QF.DE.
What is the valuation status of MODERNA INC (0QF.DE) stock?
ChartMill assigns a valuation rating of 0 / 10 to MODERNA INC (0QF.DE). This can be considered as Overvalued.
Can you provide the profitability details for MODERNA INC?
MODERNA INC (0QF.DE) has a profitability rating of 2 / 10.
Can you provide the financial health for 0QF stock?
The financial health rating of MODERNA INC (0QF.DE) is 6 / 10.